#United States #New York #Faruqi & Faruqi #PMI #Picard Medical

Urgent Notice for Picard Medical Investors

Faruqi & Faruqi, LLP, a prominent national securities law firm, has issued a critical reminder for investors in Picard Medical, Inc. (NYSE: PMI). As the firm investigates various potential claims against the company, it highlights an essential deadline for any individuals who purchased or acquired securities of Picard Medical between September 2, 2025, and October 31, 2025.

Key Information Regarding the Class Action

The deadline to seek the position of lead plaintiff in a federal securities class action is set for April 13, 2026. Those affected are encouraged to contact James (Josh) Wilson, a partner at Faruqi & Faruqi. This firm has secured hundreds of millions of dollars for investors since its inception in 1995. To discuss legal options or inquiries, stakeholders can reach him directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Allegations Against Picard Medical

According to the securities class action complaint, during the designated period, Picard Medical and its executives allegedly violated federal securities laws. The following key issues have been identified:
1. Fraudulent Stock Promotion: The company is under scrutiny for its involvement in a fraudulent stock promotion scheme that exploited social media misinformation and impersonated credible financial professionals.
2. Coordinated Share Dumping: There are claims that company insiders utilized offshore or nominee accounts to methodically offload shares, manipulating the stock’s price during an inflation campaign.
3. Omissions in Disclosures: The company failed to adequately discuss the false rumors and artificial trading activities influencing the stock price within public statements and risk disclosures, misleading investors.

Significant Stock Decline

In a shocking turn of events, the shares of Picard Medical collapsed from $13.20 on October 23, 2025, to $5.31 by October 24, 2025. This dramatic fall represents an approximate 59.8% decrease in value — marking one of the largest one-day declines witnessed since the company's initial public offering (IPO).

Faruqi & Faruqi urges anyone who may possess relevant information about Picard Medical's practices to come forward, including whistleblowers and former employees. Investors should understand their rights and the potential for recovery related to their investments.

Importance of the Lead Plaintiff Role

The role of the lead plaintiff is significant as it involves individuals with the largest financial stake in the class who are deemed adequate and typical representatives. While members of the affected class may either opt to become involved or choose to remain passive, it is important to recognize that participation in this capacity does not diminish one's potential for recovery.

Further Information

Investors wishing to learn more about the Picard Medical class action are encouraged to visit www.faruqilaw.com/PMI. Regular updates can also be found via their social media channels on LinkedIn, X, and Facebook. This serves as an essential reminder for stakeholders to be proactive regarding their investments in Picard Medical ahead of the approaching deadline.

Faruqi & Faruqi's advertising and communications are guided by legal ethics and ensure confidentiality in all communications.

In light of these developments, it is imperative for investors to stay informed and take action to protect their interests. The legal landscape surrounding securities law can be complex; thus, professional guidance is invaluable.